Authors:
RAZA A
ALVI S
BOROK RZ
SPAN L
PARCHARIDOU A
ALSTON D
RIFKIN S
ROBIN E
SHAH R
GREGORY SA
Citation: A. Raza et al., EXCESSIVE PROLIFERATION MATCHED BY EXCESSIVE APOPTOSIS IN MYELODYSPLASTIC SYNDROMES - THE CAUSE-EFFECT RELATIONSHIP, Leukemia & lymphoma, 27(1-2), 1997, pp. 111-118
Authors:
RAZA A
ALVI S
BROADYROBINSON L
SHOWEL M
CARTLIDGE J
MUNDLE SD
SHETTY VT
BOROK RZ
DAR SE
CHOPRA HK
SPAN L
PARCHARIDOU A
HINES C
GEZER S
VENUGOPAL P
LOEW J
SHOWEL J
ALSTON D
HERNANDEZ B
RIFKIN S
ROBIN E
SHAH R
GREGORY SA
Citation: A. Raza et al., CELL-CYCLE KINETIC-STUDIES IN 68 PATIENTS WITH MYELODYSPLASTIC SYNDROMES FOLLOWING INTRAVENOUS IODODEOXYURIDINE AND OR BROMODEOXYURIDINE/, Experimental hematology, 25(6), 1997, pp. 530-535
Authors:
RAZA A
MUNDLE S
SHETTY V
ALVI S
CHOPRA H
SPAN L
PARCHARIDOU A
DAR S
VENUGOPAL P
BOROK R
GEZER S
SHOWEL J
LOEW J
ROBIN E
RIFKIN S
ALSTON D
HERNANDEZ B
SHAH R
KAIZER H
GREGORY S
Citation: A. Raza et al., NOVEL INSIGHTS INTO THE BIOLOGY OF MYELODYSPLASTIC SYNDROMES - EXCESSIVE APOPTOSIS AND THE ROLE OF CYTOKINES, International journal of hematology, 63(4), 1996, pp. 265-278
Authors:
RAZA A
MUNDLE S
SHETTY V
ALVI S
CHOPRA H
SPAN L
PARCHARIDOU A
DAR S
VENUGOPAL P
BOROK R
GEZER S
SHOWEL J
LOEW J
ROBIN E
RIFKIN S
ALSTON D
HERNANDEZ B
SHAH R
KAIZER H
GREGORY S
PREISLER H
Citation: A. Raza et al., A PARADIGM SHIFT IN MYELODYSPLASTIC SYNDROMES, Leukemia, 10(10), 1996, pp. 1648-1652
Authors:
RAZA A
DAR S
GEZER S
GREGORY S
VENUGOPAL P
HINES C
MUNDLE S
SHETTY V
SPAN L
CHOPRA H
ALVI S
BOROK R
ROBIN E
RIFKIN S
ALSTON D
HERNANDEZ B
HSU WT
PREISLER H
Citation: A. Raza et al., THE STEM-CELL DISORDER IN MYELODYSPLASTIC SYNDROMES IS FURTHER CONFOUNDED BY COMPLEX CYTOKINE EFFECTS IN A STUDY OF 109 PATIENTS, Experimental hematology, 24(9), 1996, pp. 307-307
Authors:
SHETTY V
DAR S
HUSSAINI S
ALVI S
SPAN L
MUNDLE S
GEZER S
GREGORY S
VENUGOPAL P
HINES C
CHOPRA H
BOROK R
ROBIN E
RIFKIN S
ALSTON D
HERNANDEZ B
HSU WT
PREISLER H
RAZA A
Citation: V. Shetty et al., EFFECT OF ANTI-PHOSPHATIDIC DRUGS ON THE EXPRESSION OF CYTOKINES IN MYELODYSPLASTIC SYNDROMES (MDS), Experimental hematology, 24(9), 1996, pp. 573-573
Authors:
SPAN L
SHETTY V
BROADYROBINSON L
MUNDLE SD
ALVI S
BOROK R
REZA S
DAR S
BOUKHRIS T
KUMAR R
VENUGOPAL P
GEZER S
ROBIN E
RIFKIN S
HINES C
RAZA A
Citation: L. Span et al., CD34-VIVO LABELING INDEX (LI) THAN CD34 NEGATIVE CELLS IN MYELODYSPLASTIC SYNDROMES (MDS)( CELLS HAVE A LOWER IN), Blood, 88(10), 1996, pp. 365-365
Authors:
RAZA A
GEZER S
GREGORY SA
VENUGOPAL P
KAIZER H
DONG LM
SPAN L
HINES C
THOMAS R
ALVI S
MUNDLE SD
SHETTY V
BOREK R
LOEW J
REZA S
ROBIN EL
RIFKIN SD
ALSTON D
HERNANDEZ BM
SHAH R
HSU WT
DAR S
PREISLER HD
Citation: A. Raza et al., ANTI-CYTOKINE THERAPY PRODUCES RESPONSE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS), Blood, 88(10), 1996, pp. 2310-2310